Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Untangling the ErbB signalling network
2001 Standout
EGFR and cancer prognosis
2001 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Soy intake and cancer risk: A review of thein vitroandin vivodata
1994 Standout
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Cancer to bone: a fatal attraction
2011 Standout
Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer
2004
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
A High Abundance Androgen Receptor in Goldfish Brain: Characteristics and Seasonal Changes*
1988
Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications part I. Cell markers and immortalized nontumorigenic cell lines
1996
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Characterization of a 60-kDa cell surface-associated transforming growth factor-β binding protein that can interfere with transforming growth factor-β receptor binding
1997
The Economics of Reproducibility in Preclinical Research
2015 Standout
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
1996 Standout
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
2003 Standout
Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation
1992
CRISPR–Cas9 genome engineering of primary CD4+ T cells for the interrogation of HIV–host factor interactions
2018 StandoutNobel
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
Legumes and soybeans: overview of their nutritional profiles and health effects
1999 Standout
Concentration of enzymatically active prostate‐specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models
2001
Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.
1993
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Chromosomal Localization, Structure, and Regulation of the UGT2B17 Gene, Encoding a C19 Steroid Metabolizing Enzyme
1997
Medicinal mushroom modulators of molecular targets as cancer therapeutics
2005 Standout
The development of androgen-independent prostate cancer
2001 Standout
Prostate cancer expression of runt‐domain transcription factor Runx2, a key regulator of osteoblast differentiation and function
2003
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Molecular Mechanisms of Androgen Action
1994
The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens
1992
Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation
2000
Androgen receptor gene mutations in human prostate cancer
1993
Regulation of prostatic growth and function by peptide growth factors
1996
A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgens
1990
Hormone receptors in malignancy
1992
Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation
1993
Multi-targeted therapy of cancer by genistein
2008 Standout
Testosterone mediates satellite cell activation in denervated rat levator ani muscle
2001
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
2000 Standout
Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer
1996
Structure−Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC)
2010
Bcl-xL Blocks Transforming Growth Factor-β1-induced Apoptosis by Inhibiting Cytochrome c Release and Not by Directly Antagonizing Apaf-1-dependent Caspase Activation in Prostate Epithelial Cells
2001
Differentially Expressed Genes in Two LNCaP Prostate Cancer Cell Lines Reflecting Changes during Prostate Cancer Progression
2000
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
2010 Standout
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
2000 Standout
Epidermal growth factor receptor (EGFR) signaling in cancer
2005 Standout
Steroid Receptor Family: Structure and Functions
1990
Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system
1999
Up-regulation of Akt3 in Estrogen Receptor-deficient Breast Cancers and Androgen-independent Prostate Cancer Lines
1999 Standout
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
2017 Standout
Growth factor involvement in progression of prostate cancer
1998
The British Journal of Nutrition, an international journal that continues to develop
2006 Standout
Response to Flutamide Withdrawal in Advanced Prostate Cancer in Progression Under Combination Therapy
1993
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
1997 Standout
The lipocalin protein family: structure and function
1996 Standout
Prostate cancer schemes for androgen escape
2000
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
1997 Standout
Testosterone up-regulates androgen receptors and decreases differentiation of porcine myogenic satellite cells in vitro.
1996
PHOTOAFFINTTY LABELING
1989
Sex determination and sex differentiation in fish: an overview of genetic, physiological, and environmental influences
2002 Standout
A Strategy for the Selective Imaging of Glycans Using Caged Metabolic Precursors
2010 StandoutNobel
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Growth factor involvement in progression of prostate cancer.
1998
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Phytoestrogens: epidemiology and a possible role in cancer protection.
1995 Standout
Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin.
1990
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
2000 Standout
An azido-functionalized isocarbacyclin analogue acting as an efficient photoaffinity probe for a prostacyclin receptor
1992 StandoutNobel
The Costs of using Unauthenticated, Over-Passaged Cell Lines: How Much more Data do we Need?
2007
Stimulation of apolipoprotein D secretion by steroids coincides with inhibition of cell proliferation in human LNCaP prostate cancer cells.
1991
Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy
2002 Standout
Mitogen-Activated Protein Kinase Kinase Kinase 1 Activates Androgen Receptor-Dependent Transcription and Apoptosis in Prostate Cancer
1999
Annexins: From Structure to Function
2002 Standout
Citrus flavonoids: Molecular structure, biological activity and nutritional properties: A review
2007 Standout
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Overcoming Persistent Dependency on Androgen Signaling after Progression to Castration-Resistant Prostate Cancer
2010
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Androgen receptor gene mutations in human prostate cancer.
1992
Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.
1995 Standout
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Transforming growth factor β and cancer
1995
Works of J. Bolt being referenced
The human prostatic cancer cell line LNCaP and its derived sublines: An in vitro model for the study of androgen sensitivity
1991
Structure and function of the androgen receptor
1989
Mechanism of androgen action: Recent observations on the domain structure of androgen receptors and the induction of EGF-receptors by androgens in prostate tumor cells
1989
The human prostatic carcinoma cell line LNCaP and its derivatives
1989
Stimulatory effects of antiandrogens on LNCaP human prostate tumor cell growth, EGF-receptor level and acid phosphatase secretion
1990
Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones
1991
Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids
1988
Characterization of androgen receptors in a transplantable human prostatic adenocarcinoma (PC‐82)
1987
Characterization of androgen receptors after photoaffinity labelling with [3H]methyltrienolone (R1881)
1986
Characterization of the Calf Uterine Androgen Receptor and Its Activation to the Deoxyribonucleic Acid-Binding State*
1986